JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gianni D. Angelini
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soyombo, A. A.
Right arrow Articles by Newby, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soyombo, A. A.
Right arrow Articles by Newby, A. C.

J Thorac Cardiovasc Surg 1995;109:2-12
© 1995 Mosby, Inc.


SURGERY FOR ACQUIRED HEART DISEASE

Neointima formation is promoted by surgical preparation and inhibited by cyclic nucleotides in human saphenous vein organ cultures

Abigail A. Soyombo, PhD*, Gianni D. Angelini, FRCSa, Andrew C. Newby, PhD


Cardiff, Wales, and Bristol, England

Supported by grants from the British Heart Foundation.

Received for publication Jan. 28, 1994. Accepted for publication May 25, 1994. Address for reprints: Andrew Newby, PhD, Department of Cardiology, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, Wales.

Abstract

Intimal thickening is an important cause of late coronary vein graft occlusion, which no variation of surgical technique or pharmacologic intervention has been shown to reduce. We used a recently developed quantitative organ culture of human saphenous vein to investigate whether surgical preparative injury promotes neointima formation. We also investigated the effects on neointima formation of the lipid-soluble cyclic nucleotide analogs, 8-Br-cyclic adenosine monophosphate and 8-Br-cyclic guanosine monophosphate, and the phosphodiesterase inhibitor, isobutylmethylxanthine. These agents are pharmacologic mimetics of endothelium-derived prostacyclin and nitric oxide, which elevate vascular smooth muscle cyclic adenosine monophosphate and cyclic guanosine monophosphate concentrations, respectively, and may normally suppress neointima formation. Surgical preparation was found to promote intimal thickening and neointimal smooth muscle cell proliferation by 42% and 48%, respectively. 8-Br-cyclic adenosine monophosphate, 8-Br-cyclic guanosine monophosphate, or isobutylmethylxanthine (which elevated endogenous cyclic adenosine monophosphate concentrations) inhibited intimal thickening by 80%, 40%, and 72%, respectively, at a concentration of 0.1 mmol/L. The results imply that surgical techniques that avoid preparative injury and vasodilator drugs that act by elevating cyclic adenosine monophosphate or cyclic guanosine monophosphate concentrations may reduce neointima formation in vein grafts. (J THORACIC CARDIOVASC SURG 1995;109:2-12)




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Momin, N. Melikian, S. B. Wheatcroft, D. Grieve, L. C. John, A. El Gamel, M. T. Marrinan, J. B. Desai, C. Driver, R. Sherwood, et al.
The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 335 - 341.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bond, G. B. Sala-Newby, and A. C. Newby
Focal Adhesion Kinase (FAK)-dependent Regulation of S-phase Kinase-associated Protein-2 (Skp-2) Stability: A NOVEL MECHANISM REGULATING SMOOTH MUSCLE CELL PROLIFERATION
J. Biol. Chem., September 3, 2004; 279(36): 37304 - 37310.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Lorusso, S. Pentiricci, R. Raddino, T. M. Scarabelli, C. Zambelli, V. Villanacci, A. Burattin, G. Romanelli, S. Casari, R. Scelsi, et al.
Influence of Type 2 Diabetes on Functional and Structural Properties of Coronary Artery Bypass Conduits
Diabetes, November 1, 2003; 52(11): 2814 - 2820.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. M Aguilera, S. J George, J. L Johnson, and A. C Newby
Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein
Cardiovasc Res, June 1, 2003; 58(3): 679 - 688.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. A. Black, T. J. Guzik, N. E.J. West, K. Campbell, R. Pillai, C. Ratnatunga, and K. M. Channon
Minimally invasive saphenous vein harvesting: effects on endothelial and smooth muscle function
Ann. Thorac. Surg., May 1, 2001; 71(5): 1503 - 1507.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Hammerer-Lercher, J. Mair, J. Bonatti, S. B.C. Watzka, B. Puschendorf, and S. Dirnhofer
Hypoxia induces heat shock protein expression in human coronary artery bypass grafts
Cardiovasc Res, April 1, 2001; 50(1): 115 - 124.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. G. Cable, J. A. Caccitolo, N. Caplice, T. O’Brien, R. D. Simari, R. C. Daly, J. A. Dearani, C. J. Mullany, T. A. Orszulak, and H. V. Schaff
The Role of Gene Therapy for Intimal Hyperplasia of Bypass Grafts
Circulation, November 9, 1999; 100(90002): II-392 - 396.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby
Nitric oxide and the proliferation of vascular smooth muscle cells
Cardiovasc Res, August 15, 1999; 43(3): 580 - 594.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Chanda, R. Kuribayashi, K.-X. Liu, and Y. Shibata
Inhibitory effect of photooxidation on intimal and medial thickening of saphenous vein
Ann. Thorac. Surg., August 1, 1998; 66(2): 449 - 454.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. H Baker, D. Mehta, S. J George, and G. D Angelini
Prevention of vein graft failure: potential applications for gene therapy
Cardiovasc Res, September 1, 1997; 35(3): 442 - 450.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. B. Canham, H. M. Finlay, and D. R. Boughner
Contrasting structure of the saphenous vein and internal mammary artery used as coronary bypass vessels
Cardiovasc Res, June 1, 1997; 34(3): 557 - 567.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J.-A. Yang and G.-W. He
Surgical Preparation Abolishes Endothelium-Derived Hyperpolarizing Factor-Mediated Hyperpolarization in the Human Saphenous Vein
Ann. Thorac. Surg., February 1, 1997; 63(2): 429 - 433.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. L. Myers, J. J. Wizorek, A. K. Myers, M. O'Donoghue, M. T. Pettit, P. C. Kouretas, H. J. Dalton, Y. Wang, and R. A. Hopkins
MATURATION ALTERS THE PULMONARY ARTERIAL RESPONSE TO HYPOXIA AND INHALED NITRIC OXIDE IN THE PRESENCE OF ENDOTHELIAL DYSFUNCTION
J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 270 - 277.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. D. Angelini, M. B. Izzat, A. J. Bryan, and A. C. Newby
EXTERNAL STENTING REDUCES EARLY MEDIAL AND NEOINTIMAL THICKENING IN A PIG MODEL OF ARTERIOVENOUS BYPASS GRAFTING
J. Thorac. Cardiovasc. Surg., July 1, 1996; 112(1): 79 - 84.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The American Association for Thoracic Surgery.